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Abstract
Objective: In a prospective cohort study among 120,852 adult subjects the authors investigated the associations
between cigarette, cigar, pipe, environmental tobacco smoking (ETS), and bladder cancer.
Methods: In 1986 all subjects completed a questionnaire on cancer risk factors. Follow-up for incident bladder
cancer was established by linkage to cancer registries until 1992. The case–cohort analysis was based on 619 cases
and 3346 subcohort members.
Results: Compared with lifelong non-smokers the age- and sex-adjusted incidence rate ratios (RR) for ex- and
current cigarette smokers were 2.1 (95% CI 1.5–3.0) and 3.3 (95% CI 2.4–4.6), respectively. The RR for smoking
duration was 1.03 (95% CI: 1.02–1.04) per 1-year increment. The RR per 10 cigarettes/day was 1.3 (95% CI 1.2–
1.4). Tar and nicotine exposure increased bladder cancer risk only weakly. It appeared that associations of cigarette
smoking characteristics with bladder cancer risk were largely attributable to cigarette smoking duration only.
Smoking cessation, age at ﬁrst exposure, ﬁlter-tip usage, cigar and pipe smoking, and ETS were no longer associated
with bladder cancer risk after adjustment for frequency and duration of smoking.
Conclusions: The authors conclude that current cigarette smokers have a three-fold higher bladder cancer risk than
non-smokers. Ex-smokers experience a two-fold increased risk. About half of male bladder cancer and one-ﬁfth of
female bladder cancer was attributable to cigarette smoking. Other smoking types (cigar, pipe, or ETS) were not
associated with increased risks.
Introduction
Bladder cancer is the most common urologic cancer and
is the seventh most common cancer among men,
accounting for approximately 200,000 new cases per
year worldwide. Bladder cancer is considerably more
common in men than women (ratio worldwide is about
3.5:1). The incidence of this cancer varies worldwide; in
general the highest incidence is observed in North
America and Europe [1].
Narrative reviews, based on many case–control and
follow-up studies, concluded that there is strong support
for a positive association between various cigarette
smoking characteristics and bladder cancer [2–11]. Cig-
arette smoking explains the occurrence of a greater
proportion of bladder cancer than does any other known
environmental factor [2]. In a recent systematic review of
43 epidemiologic studies, based on predominantly case–
control data, we concluded that current cigarette smok-
ers may have an approximately three-fold risk of bladder
cancer compared with lifelong non-smokers [12].
However, the majority of earlier studies on cigarette
smoking have presented the association between indi-
vidual cigarette smoking characteristics on bladder
cancer adjusted only for other environmental factors
(e.g. diet, occupation). Although of interest, few studies
simultaneously included diﬀerent smoking characteris-
tics in a regression model to estimate the individual
impact of cigarette smoking features. The impact of
active cigar and pipe smoking and environmental
tobacco smoking (ETS) has also been evaluated less
often than active cigarette smoking [13–25].
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These ﬁndings prompted us to investigate the inﬂu-
ence of cigarette, cigar, pipe, and ETS on the risk of
bladder cancer in more detail in the ongoing Nether-
lands Cohort Study. In this follow-up study among
120,852 men and women, which started in 1986, detailed
information has been collected on lifetime smoking
history, including smoking status, frequency, age at ﬁrst
exposure, duration, cessation, inhalation, ﬁlter usage,
tobacco brand, and ETS, by means of a self-adminis-
tered questionnaire.
Materials and methods
Cohort
This population-based prospective cohort study on diet
and cancer started in the Netherlands in September
1986. The cohort includes 58,279 men and 62,573
women aged 55–69 years at baseline. The study popu-
lation originated from 204 municipal population regis-
tries throughout the country. The case–cohort approach
was used for data processing and analysis [26]. Cases
were enumerated from the entire cohort, while the
accumulated person-years in the cohort were estimated
from a subcohort sample. Following this approach a
subcohort of 3500 subjects (1688 men and 1812 women)
was randomly sampled from the cohort after the
baseline exposure measurement. The subcohort has
been followed up for vital status information. No
subcohort members were lost to follow-up during the
follow-up period. The study design, including data-
collection strategies, has been described in detail previ-
ously [27].
Follow-up
Follow-up for incident cancer was established by record
linkage to cancer registries and the Dutch national
database of pathology reports [28]. The completeness of
cancer follow-up was estimated to be over 96% [29]. The
presented analysis is restricted to cancer incidence in
6.3 years of follow-up, from September 1986 to Decem-
ber 1992. After excluding prevalent cases with cancer
other than skin cancer a total of 3346 subcohort
members (1630 men and 1716 women) and 619 incident
cases (532 men and 87 women) with microscopically
conﬁrmed, incident carcinomas of the urinary bladder,
ureters, renal pelvis, or urethra were identiﬁed. Of these
cases, 584 (94.3%) were diagnosed with bladder cancer
of which 559 (95.7%) were transitional cell carcinomas.
The morphologies of the remaining carcinomas were
squamous cell (n = 3), adeno (n = 6), mixed (n = 1),
or not speciﬁed (n = 15). Because the overwhelming
majority of tumors occurred in the urinary bladder, and
since the ureters, renal pelvis, and urethra are covered by
the same urothelium as the urinary bladder, the term
bladder cancer is used as a synonym for these neo-
plasms.
Questionnaire
At baseline all cohort members completed a self-
administered questionnaire on risk factors for cancer.
Tobacco smoking was addressed by questions on age at
ﬁrst exposure to smoking, age at last exposure to
smoking, smoking frequency, inhalation, and smoking
duration for cigarette, cigar, and pipe smokers. Fur-
thermore, questions were asked about the cigarette
brand most commonly smoked with or without ﬁlter-tip
and the proportion of a cigarette actually smoked (using
a visual analog scale). ETS was investigated using
questions on smoking habits of parents and spouses,
exposure to environmental smoke at work, and duration
of exposure to ETS in private and occupational settings
combined. The questionnaire data were key entered
twice and processed in a standardized manner blinded
with respect to case/subcohort status in order to
minimize observer bias in coding and interpretation of
the data.
Statistical analysis
Based on the questionnaire data we constructed, the
following are variables on active cigarette, cigar, and
pipe smoking: status (never, ex, current), frequency
(cigarettes, cigars, or pipes per day), age at ﬁrst exposure
(years), duration (years), years since cessation (years),
inhalation (yes/no), ﬁlter usage (ﬁlter, non-ﬁlter), and
ETS: spouse smoking status (never, ex, current), paren-
tal smoking (yes/no), exposure to environmental smoke
at work (high/low), and duration of exposure to ETS
(hours/day). The continuous tobacco smoking charac-
teristics were categorized into strata based on the
distribution in the subcohort. We calculated the daily
exposure to tar and nicotine for ever cigarette smokers
from cigarette brand-speciﬁc information obtained from
the Dutch Inspectorate for Health Protection, the Dutch
Foundation on Smoking and Health, and the Dutch
Foundation of the Tobacco Industry in combination
with daily cigarette smoking frequency and the percent-
age of a cigarette actually smoked.
Incidence rate ratios (RR) and corresponding 95%
conﬁdence intervals (CI) for bladder cancer were esti-
mated using exponentially distributed failure time re-
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gression models [30] with the Stata statistical software
package [31]. Standard errors were estimated using the
robust Hubert–White sandwich estimator to account for
additional variance introduced by sampling from the
cohort. This method is equivalent to the variance–
covariance estimator presented by Barlow [32] and by
Lin and Ying [33]. Tests for dose–response trends in risk
for bladder cancer over multiple categories were as-
sessed by ﬁtting ordinal exposure variables as continu-
ous terms and performing likelihood-ratio tests between
regression models with and without these variables. We
conﬁrmed constancy of the baseline hazard visually by
plotting the natural logarithm of the baseline survival
function against failure time.
The eﬀect of active tobacco smoking and ETS was
ﬁrst evaluated by regression analyses after adjustment
for age and sex and listwise deletion of missing smoking
data. Based on earlier analyses [34–36], the following
variables were subsequently considered as potential
additional confounders: intake of alcohol (g/day); coﬀee
(cups/day); tea (cups/day); water (ml/day); vegetables
(g/day); and fruit (g/day); occupational exposure to dye,
rubber, leather, or vehicle fumes (ever/never); and ﬁrst-
degree family history of bladder cancer (yes/no). Those
variables that showed a more than 10% inﬂuence on the
risk of bladder cancer when considered in a multivari-
able model were included as covariates in multivariable
analyses. Unfortunately, information on other potential
risk factors for bladder cancer (e.g. analgesic use,
urinary tract infections, or drinking-water chlorination)
was not available for this study. The adjusted incidence
rate ratios of bladder cancer for cigarette, cigar, and
pipe smokers compared with non-smokers are presented
according to the diﬀerent smoking features. Further-
more, we compared diﬀerent regression models to
identify the main predictors of bladder cancer, taking
into account the changes in eﬀect sizes and the contri-
bution to the log-likelihood of the regression model. To
prevent redundancy and collinearity, smoking status
(current smoking vs ex/never smoking), smoking inha-
lation (yes vs no/never smoking), and ﬁlter usage (non-
ﬁlter vs ﬁlter/never smoking) were recoded as indicator
variables when they were simultaneously incorporated
in one regression model with other smoking covariables.
Based on the proportion of current cigarette smokers in
the subcohort and the sex-speciﬁc age-adjusted RRs, we
estimated the population-attributable risk of bladder
cancer for men and women.
To ensure that the results were not inﬂuenced by
changes in exposure by subjects with preclinical bladder
cancer, we conducted analyses with and without cases
diagnosed in the ﬁrst 1–2 years of follow-up. The results
from these analyses were similar; therefore analyses with
all cases were presented.
Results
This distribution of bladder cancer cases and subcohort
members according to age, sex, and tobacco product
ever smoked is presented in Table 1. The age distribu-
tion among cases and subcohort members was compa-
rable. Almost all men in our study population (96% of
the cases, 90% of the subcohort members) and approx-
imately half of the women (60% of the cases, 41% of the
subcohort members) reported ever smoking cigarettes
(Table 1). Among these, the prevalence of the ex-
smokers was equal to the prevalence of the current
smokers. Most men and almost all women never smoked
Table 1. Distribution – no. (percentage in parentheses) of bladder cancer cases and subcohort members according to age, sex, and tobacco
product ever smoked; Netherlands Cohort Study (1986–1992)
Cases Subcohort
Men (n = 532) Women (n = 87) Men (n = 1630) Women (n = 1716)
Age (years)
55–59 119 (22.4) 29 (33.3) 620 (38.0) 651 (37.9)
60–64 207 (38.9) 29 (33.3) 568 (34.9) 583 (34.0)
65–69 206 (38.7) 29 (33.3) 442 (27.1) 482 (28.1)
Tobacco product
Never smokers 20 (3.8) 35 (40.2) 159 (9.8) 1019 (59.4)
Cigarette 334 (62.8) 51 (58.6) 977 (59.9) 689 (40.2)
Cigar 7 (1.3) 0 (0.0) 37 (2.3) 0 (0.0)
Pipe 3 (0.6) 0 (0.0) 5 (0.3) 0 (0.0)
Cigarette, pipe 26 (4.9) 0 (0.0) 73 (4.5) 0 (0.0)
Cigarette, cigar 74 (13.9) 1 (1.2) 196 (12.0) 4 (0.2)
Cigar, pipe 6 (1.1) 0 (0.0) 18 (1.1) 0 (0.0)
All three products 59 (11.1) 0 (0.0) 162 (9.9) 0 (0.0)
Smoking and bladder cancer 85
a cigar or a pipe during their life. If a cigar or pipe were
smoked, then it was most often combined with cigarette
smoking. Cigarettes were more often smoked solely than
in combination with other types of tobacco (Table 1).
The association between cigarette smoking and blad-
der cancer was similar in men and women for all
cigarette smoking characteristics (p-interaction = 0.34,
0.79, and 0.81 for cigarette smoking status, frequency,
and duration, respectively). Therefore, the results are
presented for men and women combined. As is shown in
Table 2, cigarette smoking clearly appeared to be
associated with bladder cancer risk. The RR of bladder
cancer was 3.3 (CI 2.4–4.6) for current cigarette smokers
compared with never smokers. The sex-speciﬁc RRs
were 3.7 (CI 2.3–6.0) and 2.4 (CI 1.4–4.1) for men and
women, respectively. Stopping smoking appeared bene-
ﬁcial, although ex-smokers still experienced an increased
RR of bladder cancer compared with lifelong non-
cigarette smokers: 2.2 (CI 1.4–3.7) and 2.3 (CI 1.3–3.9)
for men and women, respectively. Both the number of
cigarettes smoked per day and the years in which
cigarettes were smoked during a lifetime were associated
with an increased risk of bladder cancer with statistically
signiﬁcant positive trends in risk. Age at ﬁrst exposure
and years since smoking cessation were negatively
associated with the risk of bladder cancer (p-trend:
0.05 and <0.01, respectively) and inhalation increased
this risk. The RRs associated with an increase in age at
ﬁrst exposure or years of smoking cessation were 0.98
(95% CI 0.95–1.0) and 0.96 (95% CI 0.95–0.98),
respectively. It appeared that the use of ﬁlter-tipped
cigarettes did not lower the risk of bladder cancer
substantially compared with the use of non-ﬁlter-tipped
cigarettes (Table 2). Additional adjustment for other
non-smoking factors (i.e. alcohol, tea, coﬀee, water,
vegetables, fruit, occupation, and family history) or
active cigar and pipe smoking did not change the risk
estimates for cigarette smoking. Based on the results of
this study, we estimated that cigarette smoking might
account for 23% of all female bladder cancer, whereas
in men, 50% of the disease may be associated with
cigarette smoking.
Incorporation in the regression equation of age at ﬁrst
exposure and years since cessation instead of smoking
duration did not change the log-likelihood of the age-
and sex-adjusted model. The magnitude of the reciprocal
RRs for age at ﬁrst exposure (RR = 1.02) and years
since cessation (RR = 1.04) were similar to the RR for
smoking duration (RR = 1.04). After adjusting for
smoking duration, the RR per 10 cigarettes/day incre-
ment dropped from 1.3 (Table 2) to 1.2. After adjusting
for smoking frequency, however, the RR per year of
smoking (smoking duration) did not change. Cigarette
smoking frequency, however, still contributed signiﬁ-
cantly to the log-likelihood of the model even after
cigarette smoking duration was incorporated (p< 0.01).
Table 2. Incidence rate ratios (RR) for bladder cancer according to
cigarette smoking features for men and women in categorical and
continuous analyses; Netherlands Cohort Study 1986–1992
Cigarette smoking
features
Cases in
cohort
Person-years
in subcohort
RR
(95% CI)a
Never tobacco smokerb 55 7276 1.0 (ref.)
Status
Ex 263 7001 2.1 (1.5–3.0)
Current 282 5664 3.3 (2.4–4.0)
Frequency (cigarettes/day)
<5 30 1488 1.8 (1.1–2.9)
5–<10 59 1826 2.4 (1.6–3.7)
10–<15 87 2463 2.2 (1.5–3.3)
15–<20 93 1780 3.4 (2.3–5.0)
20–<25 120 2329 3.2 (2.2–4.7)
25+ 115 1900 3.7 (2.5–5.4)
p-Value for linear trend <0.01
Increment, 10 cigarettes/day 1.3 (1.2–1.4)
Duration (years)
<10 10 632 1.4 (0.68–2.9)
10–<20 39 1592 1.8 (1.1–2.8)
20–<30 63 2506 1.7 (1.1–2.6)
30–<40 125 3213 2.7 (1.9–3.9)
40–<50 220 3807 3.4 (2.4–4.8)
50+ 79 565 5.4 (3.5–8.5)
p-Value for linear trend <0.01
Increment, 1 year 1.03 (1.02–1.04)
Age at ﬁrst exposure (years)
<15 140 2059 3.5 (0.39–5.2)
15–<17 143 2796 2.9 (0.98–4.2)
17–<19 108 3056 2.3 (1.6–3.3)
19–<21 79 1806 3.1 (2.0–4.6)
21–<25 33 1012 2.5 (1.5–4.0)
25+ 33 1666 2.0 (1.3–3.3)
p-Value for linear trend 0.05
Increment, 1 yearc 0.98 (0.95–1.0)
Years since cessation
<1 295 5821 3.4 (2.5–4.7)
1–<10 112 2240 2.9 (2.0–4.3)
10–<20 71 2324 1.7 (1.1–2.5)
20–<30 54 1527 1.9 (1.2–2.9)
30+ 11 723 0.81 (0.40–1.6)
p-Value for linear trend <0.01
Increment, 1 yearc 0.96 (0.95–0.98)
Inhalation
No 95 3659 1.9 (1.3–2.8)
Yes 428 8610 3.1 (2.2–4.3)
Filter usage
Filter-tipped 85 3374 2.6 (1.8–3.8)
Non-ﬁlter-tipped 314 6063 2.6 (1.9–3.8)
a Adjusted for age (years) and sex.
b Never smoked cigars, pipe, or cigarettes.
c Lifelong non-smokers were excluded from the continuous analysis.
86 M.P.A. Zeegers et al.
The RRs for current vs ex-smokers, smoke inhalers vs
non-inhalers, and users of non-ﬁlter-tipped cigarettes vs
users of ﬁlter-tipped cigarettes dropped towards unity
after adjustment for cigarette smoking frequency and
duration. The RRs for men and women smoking <10,
10–<20, 20–<25, or >25 cigarettes per day were 0.75,
0.88, 0.73, 1.1, 1.0, and 1.2 compared with non-smokers
after adjustment for age, sex, and smoking duration,
respectively (p-trend = 0.02). The RRs for subjects
smoking for a period of <10, 10–<20, 20–<30, 30–
<40, 40–<50, or >50 years were 1.3, 1.5, 1.3, 2.1, 2.7,
and 4.6 compared with non-smokers after adjustment
for age, sex, and smoking frequency, respectively (p-
trend < 0.01). Further adjustment for cigarette smok-
ing status, inhalation, or ﬁlter usage did not change the
results substantially.
Increasing daily tar and nicotine exposures were
strong positively associated with bladder cancer risk in
age- and sex-adjusted analyses, but weakly associated
after adjustment for cigarette smoking frequency and
cigarette smoking duration (Table 3).
Because almost no women reported ever smoking
cigars or pipes, and men most commonly smoked cigars
and pipes in combination with cigarettes, the RRs from
cigar and pipe smoking compared with non-tobacco
smoking were estimated for men only, adjusted for
cigarette smoking (data not shown). Analyses for cigar
and pipe smoking solely were not possible due to sparse
data. Age confounded the association between cigar and
pipe smoking and the risk of bladder cancer. The RR for
cigar and pipe smoking indicated a statistically signif-
icant increased risk for cigar and pipe smokers. How-
ever, after additional adjustment for cigarette smoking
frequency and duration, almost none of the estimated
RRs for diﬀerent cigar or pipe smoking characteristics
remained statistically signiﬁcant. The point estimates
suggested that cigar and pipe smoking are not associated
with an increased bladder cancer risk. Only the number
of pipes smoked per day was positively associated with
bladder cancer risk, although not statistically signiﬁcant
(p-trend = 0.17).
For passive smokers, age and sex appeared to be
inﬂuential confounders. Exposure to ETS from spouses,
parents, or work was not associated with an increased
risk of bladder cancer among never tobacco smokers
(Table 4). Furthermore, duration of exposure to envi-
ronmental smoking in private and occupational settings
combined did not appear to increase the risk of bladder
cancer. Where the point estimates for parental and
work-related ETS were above unity, the estimates for
ETS from spouses and duration of exposure were lower.
However, none of the presented RRs for ETS was
statistically signiﬁcant. All estimates were based on
small numbers (Table 4).
Table 3. Adjusted incidence rate ratios (RR) for bladder cancer according to tar and nicotine exposure from ever cigarette smoking for men and
women in categorical and continuous analyses; Netherlands Cohort Study 1986–1992
Tar/nicotine Cases in cohort Person-years in
subcohort
RR (95% CI)a RR (95% CI)b
Never tobacco smokerc 55 7276 1.0 (ref.) 1.0 (ref.)
Tar (mg/day)
<100 45 1959 2.3 (1.4–3.5) 0.80 (0.40–1.60)
100–<200 68 1480 3.2 (2.1–4.9) 1.1 (0.53–2.3)
200–<300 73 1400 3.0 (2.0–4.6) 1.0 (0.46–2.2)
300–<400 46 902 3.1 (1.9–4.9) 1.0 (0.44–2.4)
400–<500 37 379 4.9 (2.9–8.5) 1.5 (0.61–3.8)
500+ 52 632 4.5 (2.8–7.2) 1.7 (0.65–4.2)
p-Value for linear trend <0.01 0.02
Increment, 100 mg/day 1.2 (1.1–1.2) 1.1 (0.93–1.3)
Nicotine (mg/day)
<10 59 2417 2.2 (1.5–3.4) 0.78 (0.39–1.5)
10–<20 89 1700 3.5 (2.3–5.2) 1.1 (0.54–2.3)
20–<30 68 1278 3.1 (2.0–4.8) 0.94 (0.42–2.1)
30–<40 36 516 3.5 (2.1–6.0) 1.1 (0.47–2.5)
40–<50 18 267 3.4 (1.8–6.4) 1.0 (0.39–2.7)
50+ 52 590 4.7 (3.0–7.6) 1.4 (0.57–3.6)
p-Value for linear trend <0.01 0.08
Increment, 10 mg/day 1.1 (1.1–1.2) 1.0 (0.94–1.1)
a Adjusted for age (years) and sex.
b Adjusted for age (years), sex, cigarette smoking frequency (cigarettes/day), and cigarette smoking duration (years).
c Never smoked cigars, pipe, and cigarettes.
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Discussion
The results of this prospective cohort study strongly
support a positive association between active cigarette
smoking and bladder cancer risk in both men and
women. Current cigarette smokers have an approxi-
mately three-fold higher risk of bladder cancer, and
ex-smokers experience a two-fold increased risk. It
appeared that associations of cigarette smoking charac-
teristics with bladder cancer risk were largely attribu-
table to cigarette smoking duration only; that cigarette
smoking cessation, age at ﬁrst exposure, and usage of
ﬁlter-tips did not inﬂuence bladder cancer risk after
adjustment of cigarette smoking frequency and dura-
tion; and that exposure to tar and nicotine weakly
increased the risk of bladder cancer. Other types of
smoking (i.e. cigar, pipe, or passive smoking) were not
associated with an increased risk.
One strength of this and other prospective studies is
that exposure was assessed before diagnosis of bladder
cancer. Therefore, recall bias is not likely to have
inﬂuenced our results. Furthermore, selection bias is not
likely, because the follow-up of cases and subcohort
members was almost complete [29, 37]. The relatively
large number of bladder cancer cases in this study was
an important strength.
Even though previous epidemiologic studies on ciga-
rette smoking associated with bladder cancer (eight
cohort and 35 case–control studies) diﬀered in method-
ology, they consistently suggested a substantial increase
in risk of bladder cancer for cigarette smokers [12]. A
recent case–control study [38] concluded that the risk of
bladder cancer may be higher in women than in men
who smoked comparable amounts of cigarettes. The
present study cannot conﬁrm these ﬁndings. For all
cigarette smoking features the RRs were similar for men
and women.
The precise mechanism by which cigarette smoking
causes bladder cancer has yet to be determined. It seems
most likely that the risk of bladder cancer is related to
some of the large number of compounds present in
smoke. 2-Naphthylamine and 4-aminobiphenyl are the
leading candidates as speciﬁc etiologic agents [4, 9, 10,
39, 40]. Several nitrosamines have also been shown to
produce bladder cancer in animal models [10]. Tars
induce bladder papillomas and carcinomas in mice [9].
However, this study suggests that smoking of low-tar
and low-nicotine cigarettes with or without ﬁlter-tips
does not reduce the risk of bladder cancer substantially
after controlling for cigarette smoking status, frequency,
and duration. To our knowledge, only one case–control
study on the association between exposure to tars and
bladder cancer risk [38], and no epidemiologic study on
nicotine exposure, has been conducted previously.
Castelao et al. [38] found no association for tar exposure
in relation to risk after adjustment for frequency,
duration, and currency of smoking. One other case–
control study reported a diminution of risk from the
smoking of light tobacco [41]. However, this risk
estimate was not adjusted for cigarette smoking dura-
tion [41]. The calculation of tar and nicotine exposure
from cigarettes might have been confounded by mis-
classiﬁcation of the cigarette brand most commonly
smoked if the validity of self-reporting for ex-smokers is
lower than for current smokers. This might be possible
because of recall bias [42]. However, the RRs for tar and
nicotine exposure from cigarettes were comparable
between ex- and current smokers. An alternative expla-
nation for the reported weak association between
exposure to tars and nicotine and bladder cancer risk
is that the smoking of light and ﬁlter-tipped cigarettes is
compensated by an increased puﬀ volume, frequency
and duration, interpuﬀ interval, or volume and duration
of inhalation [43, 44]. In the present study both
frequency and duration of cigarette smoking were
statistically signiﬁcantly higher among smokers of ﬁl-
ter-tip cigarettes.
The fact that cigarette smoking frequency and dura-
tion were consistently associated with an increased risk
of bladder cancer in both categorical and continuous
models suggests a direct positive dose–response associ-
ation. In our dataset the men vs women RR decreased
Table 4. Adjusted incidence rate ratios (RR) for bladder cancer
according to environmental tobacco smoking among never tobacco
smokers; Netherlands Cohort Study 1986–1992
Environmental tobacco
smoking (ETS)
Cases in
cohort
Person-years
in subcohort
RR
(95% CI)a
Partner smoking status
Never 19 1484 1.0 (ref.)
Ex 18 2709 0.95 (0.46–2.0)
Current 11 2116 0.74 (0.29–1.9)
Parents smoking
No 10 1212 1.0 (ref.)
Yes 42 5760 1.2 (0.56–2.4)
Work-related ETS
Low 19 3097 1.0 (ref.)
High 21 2233 1.4 (0.70–2.6)
Duration exposure ETS (hours/day)b
No exposure 18 1868 1.0 (ref.)
1–<3 13 1930 0.69 (0.33–1.4)
3+ 10 1720 0.64 (0.29–1.4)
p-Value for linear trend 0.24
Increment, 1 hour/day 0.94 (0.86–1.0)
a Adjusted for age (years) and sex.
b In private and occupational settings combined.
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from 6.7 (CI 5.3–8.5) to 3.5 (CI 2.7–4.6) after adjust-
ment for these smoking factors. Furthermore, the fact
that both age at ﬁrst exposure and years since cessation
of exposure have an inﬂuence in modifying the risk of
bladder cancer might suggest that cigarette smoke
contains both initiators and promoters for bladder
carcinogenesis. However, it appeared that the associa-
tions of these cigarette smoking characteristics with
bladder cancer risk could largely be explained by
cigarette smoking duration. The statistically signiﬁcant
RRs for all cigarette smoking characteristics decreased
substantially toward unity (and beyond) after adjust-
ment for cigarette smoking duration. This would suggest
that the promoting activity of cigarette smoke is of more
importance that the initiating activity.
The evidence of an association between bladder
cancer risk and other forms of tobacco use (i.e. cigar
and pipe) is inconsistent and, when found, generally
weaker than the association with cigarette smoking [4, 8,
10, 45]. Despite the plausibility of associations between
cigar and pipe smoking and the risk of bladder cancer
(since the smoke of both types of tobacco contains many
of the same substance as that of cigarette tobacco), it has
been suggested that their eﬀect is likely to be small [14,
17, 46]. In our study almost all men smoked a cigar or
pipe in combination with cigarettes; therefore we have
adjusted the RRs for cigarette smoking frequency and
duration to obtain less biased risk estimates for cigar
and pipe smoking. Most RRs for cigar and pipe
smoking were found to be lower than one after
adjustment for cigarette smoking, which is probably
an artefact of chance, since the CIs were rather large.
Data from experimental studies support the hypoth-
esis that non-smokers might be exposed to potential
carcinogens through the cigarette smoking of others
[47]. Mutagens have been detected in the blood and
urine of passive smokers [47, 48]. Therefore, it seems
plausible to suggest that individuals exposed to ETS
might be at increased risk of bladder cancer [17].
However, in two previous case–control studies no excess
risk of bladder cancer due to ETS was demonstrated [17,
49]. According to Burch et al. [17], it is not likely that
any association between passive smoking and bladder
cancer will be strong, considering that the association
between passive smoking and lung cancer also appears
to be relatively weak. The present study adds to this
body of evidence and endorses these earlier results.
However, the ﬁndings are still preliminary and must be
conﬁrmed in other studies.
We conclude that active cigarette smoking is strongly
associated with bladder cancer risk. Current cigarette
smokers have an approximately three-fold higher risk of
bladder cancer than non-smokers. Stopping smoking
might be beneﬁcial, although ex-smokers still experience
a two-fold increased risk. In this study about half of
male bladder cancer and one-ﬁfth of female bladder
cancer was attributable to cigarette smoking. Other
types of smoking (i.e. cigar, pipe, or passive smoking)
were not associated with an increased risk.
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